Korshie Dumor1, Michael Shoemaker-Moyle2, Ravi Nistala2,3, Adam Whaley-Connell2,3. 1. Division of Nephrology and Hypertension, Department of Medicine, University of Missouri School of Medicine, Columbia, MO, USA. Dumork@health.missouri.edu. 2. Division of Nephrology and Hypertension, Department of Medicine, University of Missouri School of Medicine, Columbia, MO, USA. 3. Harry S. Truman VA Hospital, Columbia, MO, USA.
Abstract
PURPOSE OF REVIEW: To update and review novel insights into the mechanisms, measurements, and therapeutic approaches to arterial stiffness. RECENT FINDINGS: Arterial (e.g., vascular) stiffness has been shown over time to prognosticate for cardiovascular and kidney outcomes. In this context, there has been increased interest behind the mechanisms that drive arterial stiffness beyond aging and interest in how to apply newer technologies in measurement of arterial stiffness. Pulse wave velocity has been the gold standard for measurement but industry has been innovating to improve measurement with use of single-point PWV as well as pharmacologic approaches with anti-hypertensives and oral hypoglycemic agents. Emerging data on the role of the mineralocorticoid receptor, the endothelial sodium channel (EnNaC), and uric acid in arterial stiffness are promising a number of potential therapies. Newer techniques of measuring PWV for arterial stiffness and novel therapies may soon lead to better outcomes from hypertension complications.
PURPOSE OF REVIEW: To update and review novel insights into the mechanisms, measurements, and therapeutic approaches to arterial stiffness. RECENT FINDINGS: Arterial (e.g., vascular) stiffness has been shown over time to prognosticate for cardiovascular and kidney outcomes. In this context, there has been increased interest behind the mechanisms that drive arterial stiffness beyond aging and interest in how to apply newer technologies in measurement of arterial stiffness. Pulse wave velocity has been the gold standard for measurement but industry has been innovating to improve measurement with use of single-point PWV as well as pharmacologic approaches with anti-hypertensives and oral hypoglycemic agents. Emerging data on the role of the mineralocorticoid receptor, the endothelial sodium channel (EnNaC), and uric acid in arterial stiffness are promising a number of potential therapies. Newer techniques of measuring PWV for arterial stiffness and novel therapies may soon lead to better outcomes from hypertension complications.
Authors: Pierre Boutouyrie; Danilo Fliser; David Goldsmith; Adrian Covic; Andrzej Wiecek; Alberto Ortiz; Alberto Martinez-Castelao; Bengt Lindholm; Ziad A Massy; Gultekin Suleymanlar; Rosa Sicari; Luna Gargani; Gianfranco Parati; Francesca Mallamaci; Carmine Zoccali; Gerard M London Journal: Nephrol Dial Transplant Date: 2013-09-30 Impact factor: 5.992
Authors: Teemu J Niiranen; Bindu Kalesan; Naomi M Hamburg; Emelia J Benjamin; Gary F Mitchell; Ramachandran S Vasan Journal: J Am Heart Assoc Date: 2016-10-26 Impact factor: 5.501
Authors: Liping Zhang; Yan Yang; Annayya R Aroor; Guanghong Jia; Zhe Sun; Alan Parrish; Garrett Litherland; Benjamin Bonnard; Frederic Jaisser; James R Sowers; Michael A Hill Journal: Metabolism Date: 2022-02-17 Impact factor: 8.694
Authors: Curt D Sigmund; Robert M Carey; Lawrence J Appel; Donna K Arnett; Hayden B Bosworth; William C Cushman; Zorina S Galis; Melissa Green Parker; John E Hall; David G Harrison; Alicia A McDonough; Holly L Nicastro; Suzanne Oparil; John W Osborn; Mohan K Raizada; Jacqueline D Wright; Young S Oh Journal: Hypertension Date: 2020-02-17 Impact factor: 10.190